Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis

Company Overview

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

Key Stats

• Today's Range: $20.78 to $21.17
• 50-Day Range: $19.65 to $26.44
• 52-Week Range: $14.16 to $26.91
• Volume: 37,854 shs
• Average Volume: 160,638 shs
• Market Capitalization: $1.32 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $25.67
• Consensus Rating: Buy

GRDN Stock Analysis - Frequently Asked Questions

How have GRDN shares performed this year?

Guardian Pharmacy Services' stock was trading at $20.26 at the start of the year. Since then, GRDN shares have increased by 3.2% and is now trading at $20.9050.

How were Guardian Pharmacy Services' earnings last quarter?

Guardian Pharmacy Services, Inc. (NYSE:GRDN) issued its quarterly earnings results on Monday, May, 12th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by $0.01. The business had revenue of $329.31 million for the quarter, compared to the consensus estimate of $321.21 million.
Read the conference call transcript.

When did Guardian Pharmacy Services IPO?

Guardian Pharmacy Services (GRDN) raised $102 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities served as the underwriters for the IPO.

How do I buy shares of Guardian Pharmacy Services?

Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Guardian Pharmacy Services own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META).

Company Calendar

• Last Earnings: 5/12/2025
• Today: 7/17/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Retail
• Current Symbol: NYSE:GRDN
• Previous Symbol: NYSE:GRDN
• CIK: 1802255
• Web: guardianpharmacy.com
• Phone: (404) 810-0089
• Fax: N/A
• Employees: 3,400
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Guardian Pharmacy Services: $25.67
• High Price Target: $28.00
• Low Price Target: $21.00
• Potential Upside/Downside: +22.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.14
• Quick Ratio: 0.84

Sales & Book Value

• Annual Sales: $1.28 billion
• Price / Sales: 1.03
• Cash Flow: $0.25 per share
• Price / Cash Flow: 82.39
• Book Value: $2.37 per share
• Price / Book: 8.82

Miscellaneous

• Outstanding Shares: 63,287,000
• Free Float: 22,967,000
• Market Cap: $1.32 billion
• Optionable: N/A
• Beta: N/A